Our laboratory has identified
seu-2 as a suppressor of axon guidance defects induced by ectopic UNC-5 expression (Colavita & Culotti (1998) Dev. Biol. 194: 72-85). The
seu-2(
ev523) mutation on its own does not cause axon guidance defects, but was probably picked up in this suppressor screen because the screen is sensitized to the dose of components of the UNC-5 axon guidance signaling pathway. Since the
seu-2(
ev523) mutant does not show any obvious phenotype, we had to use the rescue of the dorsalward axon guidance phenotype induced by ectopically expressed UNC-5 to identify a rescuing region. Using overlapping cosmids, we identified a rescuing fragment containing two predicted genes that encode a putative seven-pass transmembrane protein and a serine-threonine phosphatase PP2A. The two coding regions are very close and are likely to constitute an operon. To determine which one of these genes is actually
seu-2 , we are attempting to rescue the mutant phenotype with constructs carrying a premature termination mutations in each gene. The sequence analysis of the transcripts from both genes has not revealed any amino-acid change suggesting that the
seu-2(
ev623) mutation may affect untranslated regions of the gene. We are investigating the expression pattern of the gene using a translational fusion to GFP. Preliminary results reveal expression in dorsal and ventral muscles, in motorneurons and in amphid and phasmid neurons throughout development. We will check expression in touch neurons by using a longer promoter region and observing the reporter transgene expression during embryonic development. To further characterize the
seu-2 locus genetically and molecularly, we are currently doing a non-complementation screen to isolate new mutant alleles of the
seu-2 gene. The molecular analysis of the new mutations should provide new insights into the function of SEU-2 and possibly identify different functional domains of the protein.